ONWARD_Logotype®_Red.png
ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA
February 29, 2024 01:41 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD_Logotype®_Red.png
KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
February 09, 2024 01:30 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 09, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and...
ONWARD_Logotype®_Red.png
ONWARD® MEDICAL ANNOUNCES PRESENTATION AT BIOCAPITAL EUROPE
February 07, 2024 15:55 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Feb. 07, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD_Logotype®_Red.png
ONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)
January 25, 2024 17:11 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Jan. 25, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and...
ONWARD_Logotype®_Red.png
ONWARD® to Participate in Basel Healthtech Conference 2024
January 22, 2024 14:03 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD_Logotype®_Red.png
ONWARD® to Participate in Degroof Petercam Healthcare Conference
January 19, 2024 12:48 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Jan. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD_Logotype®_Red.png
ONWARD® Announces Start of HemON NL Clinical Study
January 18, 2024 01:30 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Jan. 18, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD® Reports Q3 B
ONWARD® Reports Q3 Business Update and Year-To-Date Highlights
November 16, 2023 01:30 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Completing activities required for ARC-EX® FDA submission     Expanded HemON Study as precursor to ARC-IM® Empower BP pivotal...
ONWARD versterkt man
ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen
November 16, 2023 01:30 ET | ONWARD Medical NV
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, Nov. 16, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), het medische technologiebedrijf dat innovatieve therapieën...
ONWARD renforce son
ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing
November 16, 2023 01:30 ET | ONWARD Medical NV
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 16 nov. 2023 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext: ONWD), société de technologie médicale créant des thérapies innovantes...